https://www.selleckchem.com/pr....oducts/Cyclopamine.h
In both test settings, participants with hearing loss rated pleasant sounds as less pleasant than did their normal hearing counterparts. Future work is warranted to explain the ratings of participants with normal hearing. In both test settings, participants with hearing loss rated pleasant sounds as less pleasant than did their normal hearing counterparts. Future work is warranted to explain the ratings of participants with normal hearing. As a novel treatment modality, tumor treating fields (TTFields) exert low-intensity, medium-fr
Like
Comment
Share
